Michele Manto has been promoted to the role of chief commercial officer at Galapagos NV as the company prepares for a regulatory decision and the expected launch of its lead product for rheumatoid arthritis filgotinib. Mr Manto has been working in a commercial capacity at Galapagos since 2017. Prior to this, he was head of marketing for rheumatology medicines at AbbVie Inc. He started his career at McKinsey & Company and holds an MBA from the business school INSEAD.
Galapagos announced the appointment on 23 January 2020.
Copyright 2020 Evernow Publishing Ltd